Navigation Links
Commercial dry petfood has significant benefits for oral health in cats and dogs
Date:10/13/2011

Oct. 13, 2011 - In a nationwide study of more than 17,000 dogs and 6,000 cats visiting over 700 Polish veterinary surgeries, researchers have shown that including at least some dry food in the diet has significant benefits for oral health in cats and dogs compared with home-prepared alternatives. This research was conducted by Mars Petcare Poland and the WALTHAM Centre for Pet Nutrition - the fundamental science centre supporting Mars Petcare brands such as PEDIGREE, WHISKAS and ROYAL CANIN.

The study, which was run in collaboration with the Polish Small Animal Veterinary Association, showed that introducing an element of commercial dry food into the diets of cats and dogs led to a marked improvement in oral health status. Benefits were also seen when daily tooth brushing or dental chews were introduced. The survey also found that the probability of oral health problems was significantly higher when the cats and dogs were fed home-prepared foods.

"Gum disease is one of the most frequently diagnosed oral diseases in cats and dogs, with signs ranging from mild gingivitis to tooth loss," noted WALTHAM scientist and study author Dr. Catherine Buckley. "Diet and level of oral care play a key role in determining the oral health status of cats and dogs. While tooth brushing, dental snacks and regular veterinary check-ups are still the gold standard in terms of maintaining good oral hygiene, this study shows that including some dry food in the feeding regimen can have considerable benefits for pets' oral health." In practical terms, this study demonstrates that feeding some of the food portion as dry food, and including tooth brushing and dental chews in a care regimen is likely to help maintain the oral health status of cats and dogs.


'/>"/>
Contact: Dr. Abigail Stevenson
Abigail.Stevenson@effem.com
44-166-441-5409
WALTHAM Centre for Pet Nutrition
Source:Eurekalert

Page: 1

Related biology news :

1. SuviCa Inc. of Boulder to commercialize CU-Boulder cancer screening technology
2. A scientific go for commercial production of vitamin-D enhanced mushrooms
3. Plan to one day end the use of environmentally harmful chemicals on commercial crops developed
4. Sweetpotato foundation seed tested in commercial operations
5. Gene therapy success depends on ability to advance viral delivery vectors to commercialization
6. CHOP partners with Vascular Magnetics, Inc. to pursue commercial potential of blood vessel research
7. Ben-Gurion U. and PTT Chemical sign R&D agreement to commercialize green algae strain
8. NextCAT Inc. secures $250,000 to commercialize biodiesel technology developed at Wayne State
9. Paper mulches evaluated for commercial vegetable production
10. Biotech collaboration established to commercialize research reagents
11. Progress toward first commercial repellent for East Coasts stinker
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... WEST LAFAYETTE, Indiana (PRWEB) , ... ... ... a division of Albany Molecular Research Inc. has further extended its industry ... sector. This service offers state-of-the-art cGMP techniques and methods for the ...
(Date:2/15/2017)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial ... full year ended December 31, 2016. ... we continued to demonstrate strong growth in our ... said Mihael H. Polymeropoulos, M.D., Vanda,s President and ... 2017 milestones underscores Vanda,s commitment to bringing important ...
Breaking Biology Technology: